Evidence map›Paper›PMID 24761229›Full record

ArticleBone research2013

Inhibition of Rgs10 Expression Prevents Immune Cell Infiltration in Bacteria-induced Inflammatory Lesions and Osteoclast-mediated Bone Destruction.

Sen Yang, Liang Hao, Matthew McConnell, Xuedong Zhou, Min Wang, Yan Zhang, John D Mountz, Michael Reddy, Paul D Eleazer, Yi-Ping Li and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Bone research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Sen YangDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Liang HaoDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Matthew McConnellDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Xuedong ZhouThe State Key Laboratory of Oral Diseases, West China College of Stomatology, Sichuan University, Sichuan, P. R. China.
Min WangThe State Key Laboratory of Oral Diseases, West China College of Stomatology, Sichuan University, Sichuan, P. R. China.
Yan ZhangDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
John D MountzDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Michael ReddyDepartment of Periodontology, University of Alabama at Birmingham School of Dentistry, Birmingham, Alabama, USA.
Paul D EleazerDepartment of Endodontics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Yi-Ping LiDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Wei ChenDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
University of Alabama at Birmingham · USSichuan University · CN

Funding

ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
UAB Core Center for Musculoskeletal DisordersP30AR046031 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PONNAZHAGAN, SELVARANGAN · 2001 to 2010
$5.6M
TRANSCRIPTION FACTORS CONTROL OSTEOCLAST DIFFERENTIATIONR01AR044741 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LI, YI-PING · 1999 to 2016
$5.1M
Inhibiting Periodontitis by Targeting Cathepsin K and Attenuating TLR SignalingR01DE023813 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LI, YI-PING · 2014 to 2023
$3.9M
The Role of AML1 in Osteoclastogenesis and Osteoclast Gene ExpressionR01AR055307 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LI, YI-PING · 2009 to 2010
$1.1M
Novel RNAi Inhibits Both Inflammation and Bone Resorption in Oral DiseasesRC1DE020533 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LI, YI-PING · 2009 to 2010
$919k
NIAMS NIH HHS P30 AR046031NIAMS NIH HHS P30 AR048311NIAMS NIH HHS R01 AR044741NIAMS NIH HHS R01 AR055307NIDCR NIH HHS R01 DE023813NIDCR NIH HHS RC1 DE020533
6 · The paper itself

Abstract

Regulator of G-protein Signaling 10 (Rgs10) plays an important function in osteoclast differentiation. However, the role of Rgs10 in immune cells and inflammatory responses, which activate osteoclasts in inflammatory lesions, such as bacteria-induced periodontal disease lesions, remains largely unknown. In this study, we used an adeno-associated virus (AAV-) mediated RNAi (AAV-shRNA-

Indexed as

AAV-mediated RNAi knockdownbone resorptiongene therapygingival inflammationimmune cellperiodontal diseaseRgs10

Identifiers

PMID24761229
PMCPMC3994128
OpenAlexW2080485389

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.